Eris Lifesciences has informed that the Trading Window of the Company shall remain closed on 4th December, 2019 and 5th December, 2019. Further pursuant to Clause 4 of Schedule B of SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company, all the Designated Persons and their immediate relatives are requested not to trade in securities of the Company during the closure of the trading window.
The above information is a part of company’s filings submitted to BSE
